N-Acetyl-L-phenylalanine is an essential amino acid produced for medical feed and nutritional applications. It appears in large amount in urine of patients with phenylketonuria which is a human genetic disorder due to the lack of phenylalanine hydroxylase the enzyme necessary to metabolize phenylalanine to tyrosine.

Used as pharmaceutical intermediates for synthesis of drug carbamazepine.

Clivatuzumab is a humanized anti-myxinomab, which can target the MUC1 epitope highly expressed on the surface of most pancreatic cancer cells, and has a good therapeutic effect on a variety of tumor cells.